$146.51
-9.61-6.16%
Last update: Nov 6, 7:58 PM
Insulet Corp
PODDNASDAQ
The average analyst price target for Insulet is $229.03, 56.0% above the current price. Of 22 analysts, 14 rate it Buy and 8 Hold. Targets range from $144 to $450. The latest change came on Nov 6, 2026, when Barclays raised its price target on Insulet from $150 to $165 and kept an Equal-Weight rating.
Price Target Range — 8 Quarters
Analyst Consensus — 22 Analysts
Rating Trend — Last 9 Months
